How much did community pharmacy funding increase by in 2026/27?

Short answer: the often-quoted £340 million increase is the uplift announced for community pharmacy funding in England for 2025/26—not, by itself, the year-on-year increase for 2026/27. The 2026/27 figure needs to be compared with the previous year’s funding allocation, using the same definition of funding in both years.

That distinction matters. “Funding increased by £340 million” can describe a change from one baseline to another, a settlement for a particular year, or money allocated across several parts of the contract. It does not automatically mean pharmacies receive £340 million more in 2026/27 than they received in 2025/26.

This article explains how to read the headline, why a CPCF uplift matters to pharmacies facing rising workload, and why extra funding alone will not fix staffing gaps. It also looks at how apprenticeships can support a practical, planned workforce pipeline.

What does the £340 million increase refer to?

The £340 million figure is associated with the community pharmacy funding settlement for 2025/26 in England. It is important not to relabel it as the 2026/27 year-on-year increase unless the published figures for both years support that comparison.

For a clear comparison, check three things before quoting a funding number:

• The financial year: Is the figure for 2025/26 or 2026/27?
• The comparison year: Is the increase measured against the previous year, or another funding baseline?
• What is included: Does the total cover the whole contractual framework, specific services, or a particular payment element?

These details are not fine print. A headline increase in the national settlement is not the same as a guaranteed increase in every pharmacy’s income. Individual payments depend on the contract, service activity and applicable arrangements.

How to understand a CPCF uplift in 2026/27

The Community Pharmacy Contractual Framework (CPCF) sets out the services and funding arrangements for community pharmacy in England. A CPCF uplift is a change to https://bizzmarkblog.com/does-more-nhs-funding-automatically-solve-pharmacy-staffing-shortages/ funding within that framework. To describe it accurately, compare the total funding for 2026/27 with the total for 2025/26 on a like-for-like basis.

Question Why it matters Which year does the headline cover? An uplift announced for 2025/26 is not automatically the uplift for 2026/27. What is the previous-year baseline? You need it to calculate the actual year-on-year change. Is the figure a total or an increase? A total annual settlement and the amount added to it answer different questions. Does it reflect inflation and operating costs? A larger cash total does not necessarily mean greater purchasing power or more money for each pharmacy.

So, if you are writing a business plan or briefing your team, avoid saying “community pharmacy funding rose by £340 million in 2026/27” unless the 2026/27 settlement specifically supports that statement. A more careful description is: “The £340 million figure relates to the 2025/26 settlement; check the published 2026/27 CPCF figures to establish the separate year-on-year change.”

Why the funding question matters now

Community pharmacies are being asked to deliver more care while managing day-to-day pressures: medicine supply, clinical services, patient queries, staff cover and the work that comes with running a safe dispensary. Funding matters because it affects the resources available to deliver services and employ the people who make them possible.

But a national increase does not solve every local problem. A pharmacy may still struggle to fill shifts, retain experienced staff or free a pharmacist to deliver clinical work. The practical question for owners is not only “How much funding is available?” It is also “Can we recruit and develop enough people to deliver the work safely?”

Pharmacy First has added workload in primary care

Pharmacy First gives community pharmacies a larger role in responding to some common conditions and supporting patients who might otherwise seek care elsewhere in primary care. That is a meaningful service shift. It can improve access for patients, but it also brings work that takes staff time.

Each consultation needs the right person, appropriate clinical judgement, accurate records and a clear route for referral when a patient needs another service. The surrounding tasks matter too: managing the queue, answering calls, dealing with prescriptions and keeping routine dispensing moving.

In a well-staffed pharmacy, teams can organise those demands. In a thinly staffed one, the same service can compete with core work for attention. That is why workforce capacity should be part of any discussion about the CPCF uplift. Funding can support delivery, but it does not instantly create trained staff or remove the time needed to develop them.

Workforce numbers are falling—and vacancies affect the whole rota

Community pharmacy has faced workforce pressure, including difficulties recruiting and retaining staff. The effects show up in familiar ways: unfilled shifts, greater pressure on the people who remain, less flexibility to cover sickness and fewer opportunities to release staff for training.

When a rota has no slack, one absence can force a manager to rearrange the day. A pharmacist may have less time for clinical services. A dispenser may carry a heavier queue. Managers can spend more time trying to cover shifts and less time supporting staff development.

It is tempting to treat this as a recruitment problem alone. Often it is a capacity problem: the pharmacy needs enough people with the right skills, at the right times, to cover both routine work and newer services. Recruitment can help, but a vacancy advert cannot produce an experienced team overnight.

Why recruitment-only strategies fail in a tight labour market

In a tight labour market, pharmacies compete for a limited pool of candidates. Posting another advert may be necessary, but it is not a complete workforce plan. It can be slow, especially when several local employers need similar skills. A successful hire also takes time to settle in and learn the pharmacy’s systems.

Recruitment-only approaches can leave owners repeating the same cycle: advertise, interview, cover the rota while waiting, then start again when someone leaves. That cycle becomes harder to manage when the team already has little time to train a new colleague.

A more resilient plan combines external recruitment with retention and development. That means being clear about roles, offering useful support to new starters, and creating ways for people to build skills while they work. Apprenticeships can form part of that plan—not as a substitute for experienced staff, but as a structured route to develop future colleagues.

Apprenticeships can create a staffing pipeline

An apprenticeship is a paid job with planned training. It gives an employee the opportunity to develop occupational skills while contributing to the workplace, with training and assessment arranged around the requirements of the programme. It is not a shortcut to replacing experienced staff, and it should not be treated as cheap labour.

For a pharmacy, the value is in building capability over time. A new apprentice needs supervision, feedback and protected time for learning. In return, the employer can develop someone in the context of its own services, systems and patient needs. That can make apprenticeships a useful part of a longer-term workforce plan.

What a workable apprenticeship plan looks like week to week

A pipeline only works if someone can explain how it works in practice. Before starting an apprenticeship, map the learner’s working hours, training time, supervision and cover. For example, a manager might:

1. Agree the role and learning plan: identify the tasks the apprentice can do, the skills they need to build and who will supervise them.
2. Protect time for training: plan learning into the rota rather than assuming it will happen after a busy shift.
3. Set regular check-ins: discuss progress, confidence, workload and any gaps in learning with the apprentice and training provider.
4. Review the rota: make sure supervision does not leave the rest of the team short during busy periods.
5. Plan what comes next: identify the role, responsibilities and further development that could follow completion.

That is the difference between using an apprenticeship as a real workforce route and simply adding a learner to an already stretched team. It also helps owners assess whether they have the supervision capacity to start a programme responsibly.

Finding pharmacy apprenticeship training

Pharmacy owners and managers looking into training options can review the pharmacy apprenticeship category at tendtraining.co.uk. Check the available programmes, eligibility and delivery arrangements directly with the provider, then consider how each option fits the roles and support capacity in your pharmacy.

Before committing, ask how the training will fit around working hours, what support the learner and employer receive, and what responsibilities sit with the Find more information pharmacy. Good planning at the start makes it easier to protect learning time and keep patient-facing work safe.

Funding and workforce planning need to move together

A year on year funding increase can help the sector respond to pressure, but the amount alone cannot tell an owner whether their pharmacy has enough capacity. The team still needs the right mix of people, skills and cover to deliver services reliably.

For a practical workforce review, start with the rota rather than a slogan. List the shifts that are hardest to cover, the roles that depend on one person, and the times Pharmacy First or other services compete with dispensing. Then decide which gaps need an experienced hire and which skills could be developed internally through structured training.

• Use recruitment to fill urgent gaps and bring in experience.
• Use retention measures to reduce avoidable turnover.
• Use apprenticeships to develop skills over a planned period.
• Build supervision and training time into the rota from the beginning.
• Review workload and staffing regularly, rather than waiting for the next vacancy.

The bottom line on the £340 million increase

The figure to handle carefully is £340 million: it relates to the community pharmacy funding settlement for 2025/26, and should not be presented as the 2026/27 year-on-year increase without a like-for-like comparison of the published totals. The right 2026/27 answer depends on the relevant CPCF funding figures and the baseline used.

For pharmacy owners, the bigger point is that funding and staffing are connected. Pharmacy First has added work in primary care; workforce pressure makes that work harder to absorb; and recruitment alone may not keep pace in a tight labour market. A planned apprenticeship route can help develop future colleagues, provided the pharmacy has time to supervise and train them.

So when you see a headline about a CPCF uplift, check the year, the denominator and what the figure includes. Then ask the operational question that matters on Monday morning: do you have enough people, with the right skills, to deliver the service safely?